nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—CYP3A4—Temozolomide—melanoma	0.0186	0.576	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Vemurafenib—melanoma	0.0102	0.316	CbGbCtD
Medroxyprogesterone Acetate—SHBG—hindlimb—melanoma	0.00474	0.198	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—Docetaxel—melanoma	0.00349	0.108	CbGbCtD
Medroxyprogesterone Acetate—HSD3B2—head—melanoma	0.00216	0.09	CbGeAlD
Medroxyprogesterone Acetate—Testosterone Propionate—CYP17A1—melanoma	0.00213	0.282	CrCbGaD
Medroxyprogesterone Acetate—PGR—blood vessel—melanoma	0.00204	0.0851	CbGeAlD
Medroxyprogesterone Acetate—SHBG—neck—melanoma	0.00162	0.0676	CbGeAlD
Medroxyprogesterone Acetate—ESR1—blood vessel—melanoma	0.00159	0.0666	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—lymph node—melanoma	0.00151	0.063	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—mammalian vulva—melanoma	0.00127	0.0531	CbGeAlD
Medroxyprogesterone Acetate—ESR1—neck—melanoma	0.00114	0.0476	CbGeAlD
Medroxyprogesterone Acetate—Progesterone—CYP17A1—melanoma	0.000979	0.13	CrCbGaD
Medroxyprogesterone Acetate—NR3C1—neck—melanoma	0.000842	0.0351	CbGeAlD
Medroxyprogesterone Acetate—AR—skin of body—melanoma	0.000752	0.0314	CbGeAlD
Medroxyprogesterone Acetate—Erythema—Dactinomycin—melanoma	0.000712	0.00131	CcSEcCtD
Medroxyprogesterone Acetate—Pain in extremity—Docetaxel—melanoma	0.000711	0.00131	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Bleomycin—melanoma	0.000708	0.00131	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Bleomycin—melanoma	0.000706	0.0013	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Vemurafenib—melanoma	0.000704	0.0013	CcSEcCtD
Medroxyprogesterone Acetate—Migraine—Docetaxel—melanoma	0.0007	0.00129	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Temozolomide—melanoma	0.000699	0.00129	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Temozolomide—melanoma	0.000691	0.00128	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Temozolomide—melanoma	0.00069	0.00127	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Bleomycin—melanoma	0.000688	0.00127	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Temozolomide—melanoma	0.000687	0.00127	CcSEcCtD
Medroxyprogesterone Acetate—AR—mammalian vulva—melanoma	0.000686	0.0286	CbGeAlD
Medroxyprogesterone Acetate—Dizziness—Vemurafenib—melanoma	0.00068	0.00125	CcSEcCtD
Medroxyprogesterone Acetate—Progesterone—CYP1B1—melanoma	0.000679	0.0899	CrCbGaD
Medroxyprogesterone Acetate—Alopecia—Carmustine—melanoma	0.000676	0.00125	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Temozolomide—melanoma	0.000671	0.00124	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Carmustine—melanoma	0.000671	0.00124	CcSEcCtD
Medroxyprogesterone Acetate—Ataxia—Docetaxel—melanoma	0.000669	0.00123	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Temozolomide—melanoma	0.000668	0.00123	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Temozolomide—melanoma	0.000667	0.00123	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Carmustine—melanoma	0.000666	0.00123	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Carmustine—melanoma	0.000666	0.00123	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Temozolomide—melanoma	0.000664	0.00122	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Dactinomycin—melanoma	0.000661	0.00122	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Dactinomycin—melanoma	0.000658	0.00121	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Vemurafenib—melanoma	0.000654	0.00121	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Temozolomide—melanoma	0.000654	0.00121	CcSEcCtD
Medroxyprogesterone Acetate—Dry skin—Docetaxel—melanoma	0.000652	0.0012	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Bleomycin—melanoma	0.00065	0.0012	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Bleomycin—melanoma	0.00065	0.0012	CcSEcCtD
Medroxyprogesterone Acetate—Orthostatic hypotension—Docetaxel—melanoma	0.000649	0.0012	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Vemurafenib—melanoma	0.000648	0.0012	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Temozolomide—melanoma	0.000648	0.0012	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Vemurafenib—melanoma	0.000648	0.0012	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Carmustine—melanoma	0.000645	0.00119	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Vemurafenib—melanoma	0.000644	0.00119	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Temozolomide—melanoma	0.000644	0.00119	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Temozolomide—melanoma	0.000644	0.00119	CcSEcCtD
Medroxyprogesterone Acetate—Breast disorder—Docetaxel—melanoma	0.000643	0.00119	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Bleomycin—melanoma	0.000642	0.00118	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Dactinomycin—melanoma	0.000642	0.00118	CcSEcCtD
Medroxyprogesterone Acetate—Testosterone—CYP1B1—melanoma	0.000641	0.085	CrCbGaD
Medroxyprogesterone Acetate—Cramp muscle—Docetaxel—melanoma	0.00064	0.00118	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—lymph node—melanoma	0.000637	0.0266	CbGeAlD
Medroxyprogesterone Acetate—Nasopharyngitis—Docetaxel—melanoma	0.000636	0.00117	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Temozolomide—melanoma	0.000631	0.00116	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Bleomycin—melanoma	0.000628	0.00116	CcSEcCtD
Medroxyprogesterone Acetate—Alanine aminotransferase increased—Docetaxel—melanoma	0.000627	0.00116	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—eye—melanoma	0.000626	0.0261	CbGeAlD
Medroxyprogesterone Acetate—Tremor—Carmustine—melanoma	0.000624	0.00115	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Bleomycin—melanoma	0.000623	0.00115	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Bleomycin—melanoma	0.000623	0.00115	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Temozolomide—melanoma	0.000623	0.00115	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Bleomycin—melanoma	0.000619	0.00114	CcSEcCtD
Medroxyprogesterone Acetate—PGR—head—melanoma	0.000616	0.0257	CbGeAlD
Medroxyprogesterone Acetate—Anaemia—Carmustine—melanoma	0.000616	0.00114	CcSEcCtD
Medroxyprogesterone Acetate—Dysphagia—Docetaxel—melanoma	0.000615	0.00113	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Carmustine—melanoma	0.000612	0.00113	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Vemurafenib—melanoma	0.000611	0.00113	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Bleomycin—melanoma	0.00061	0.00113	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Dactinomycin—melanoma	0.000606	0.00112	CcSEcCtD
Medroxyprogesterone Acetate—Bronchospasm—Docetaxel—melanoma	0.000605	0.00112	CcSEcCtD
Medroxyprogesterone Acetate—Tremor—Temozolomide—melanoma	0.000603	0.00111	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Dactinomycin—melanoma	0.000599	0.0011	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Temozolomide—melanoma	0.000597	0.0011	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Temozolomide—melanoma	0.000595	0.0011	CcSEcCtD
Medroxyprogesterone Acetate—Drospirenone—PTGS2—melanoma	0.000594	0.0787	CrCbGaD
Medroxyprogesterone Acetate—Anorexia—Bleomycin—melanoma	0.000594	0.0011	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Temozolomide—melanoma	0.000592	0.00109	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Temozolomide—melanoma	0.000588	0.00109	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Bleomycin—melanoma	0.000582	0.00107	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Dactinomycin—melanoma	0.000581	0.00107	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Temozolomide—melanoma	0.000581	0.00107	CcSEcCtD
Medroxyprogesterone Acetate—Megestrol acetate—ABCB1—melanoma	0.000579	0.0766	CrCbGaD
Medroxyprogesterone Acetate—Vertigo—Temozolomide—melanoma	0.000579	0.00107	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Carmustine—melanoma	0.000577	0.00107	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Dactinomycin—melanoma	0.000577	0.00107	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Temozolomide—melanoma	0.000569	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Dactinomycin—melanoma	0.000569	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Bleomycin—melanoma	0.000568	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Carmustine—melanoma	0.000567	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Carmustine—melanoma	0.000567	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Carmustine—melanoma	0.000565	0.00104	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Bleomycin—melanoma	0.000559	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—Weight increased—Docetaxel—melanoma	0.000559	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Temozolomide—melanoma	0.000558	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—Weight decreased—Docetaxel—melanoma	0.000556	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Bleomycin—melanoma	0.000555	0.00102	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Dactinomycin—melanoma	0.000554	0.00102	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Carmustine—melanoma	0.000548	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Temozolomide—melanoma	0.000548	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Temozolomide—melanoma	0.000548	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Infestation—Docetaxel—melanoma	0.000548	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Infestation NOS—Docetaxel—melanoma	0.000548	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Temozolomide—melanoma	0.000546	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—skin of body—melanoma	0.000545	0.0227	CbGeAlD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000544	0.001	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Carmustine—melanoma	0.000544	0.001	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Temozolomide—melanoma	0.000542	0.000999	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Bleomycin—melanoma	0.000542	0.000999	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Carmustine—melanoma	0.00054	0.000997	CcSEcCtD
Medroxyprogesterone Acetate—Acute coronary syndrome—Docetaxel—melanoma	0.00054	0.000997	CcSEcCtD
Medroxyprogesterone Acetate—Myocardial infarction—Docetaxel—melanoma	0.000537	0.000991	CcSEcCtD
Medroxyprogesterone Acetate—Neuropathy peripheral—Docetaxel—melanoma	0.000537	0.000991	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Temozolomide—melanoma	0.000536	0.000989	CcSEcCtD
Medroxyprogesterone Acetate—Stomatitis—Docetaxel—melanoma	0.000534	0.000986	CcSEcCtD
Medroxyprogesterone Acetate—Jaundice—Docetaxel—melanoma	0.000534	0.000986	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Carmustine—melanoma	0.000532	0.000982	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Carmustine—melanoma	0.000531	0.000979	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Temozolomide—melanoma	0.00053	0.000978	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000529	0.000977	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Temozolomide—melanoma	0.000526	0.00097	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Temozolomide—melanoma	0.000526	0.00097	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Temozolomide—melanoma	0.000522	0.000963	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Carmustine—melanoma	0.000518	0.000956	CcSEcCtD
Medroxyprogesterone Acetate—Hepatobiliary disease—Docetaxel—melanoma	0.000518	0.000956	CcSEcCtD
Medroxyprogesterone Acetate—Epistaxis—Docetaxel—melanoma	0.000517	0.000954	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Temozolomide—melanoma	0.000515	0.000951	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Temozolomide—melanoma	0.000515	0.000949	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Bleomycin—melanoma	0.000513	0.000947	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Temozolomide—melanoma	0.00051	0.000942	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Carmustine—melanoma	0.000508	0.000938	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Temozolomide—melanoma	0.000508	0.000937	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Dactinomycin—melanoma	0.000505	0.000932	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Dactinomycin—melanoma	0.000501	0.000924	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Temozolomide—melanoma	0.000501	0.000924	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—mammalian vulva—melanoma	0.000497	0.0207	CbGeAlD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Carmustine—melanoma	0.000495	0.000914	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Bleomycin—melanoma	0.000495	0.000913	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Docetaxel—melanoma	0.000494	0.000912	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Bleomycin—melanoma	0.000493	0.000909	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Docetaxel—melanoma	0.000492	0.000908	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Docetaxel—melanoma	0.000492	0.000908	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Carmustine—melanoma	0.000492	0.000908	CcSEcCtD
Medroxyprogesterone Acetate—AR—head—melanoma	0.000491	0.0205	CbGeAlD
Medroxyprogesterone Acetate—Paraesthesia—Carmustine—melanoma	0.000488	0.000901	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Docetaxel—melanoma	0.000488	0.000901	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Docetaxel—melanoma	0.000486	0.000896	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Carmustine—melanoma	0.000485	0.000895	CcSEcCtD
Medroxyprogesterone Acetate—Oedema peripheral—Docetaxel—melanoma	0.000485	0.000894	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Carmustine—melanoma	0.000483	0.000892	CcSEcCtD
Medroxyprogesterone Acetate—Connective tissue disorder—Docetaxel—melanoma	0.000483	0.000892	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Docetaxel—melanoma	0.000482	0.00089	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—head—melanoma	0.000482	0.0201	CbGeAlD
Medroxyprogesterone Acetate—Feeling abnormal—Dactinomycin—melanoma	0.000479	0.000883	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Temozolomide—melanoma	0.000479	0.000883	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Temozolomide—melanoma	0.000475	0.000877	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Dactinomycin—melanoma	0.000475	0.000877	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Docetaxel—melanoma	0.000474	0.000875	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Carmustine—melanoma	0.000473	0.000872	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Temozolomide—melanoma	0.000472	0.000871	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Carmustine—melanoma	0.000469	0.000866	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Temozolomide—melanoma	0.000469	0.000865	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Temozolomide—melanoma	0.000467	0.000862	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Docetaxel—melanoma	0.000465	0.000858	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Carmustine—melanoma	0.000465	0.000858	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Temozolomide—melanoma	0.000463	0.000854	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Docetaxel—melanoma	0.00046	0.000848	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Dactinomycin—melanoma	0.000459	0.000848	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Dactinomycin—melanoma	0.000459	0.000848	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Bleomycin—melanoma	0.000459	0.000847	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Temozolomide—melanoma	0.000457	0.000843	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Docetaxel—melanoma	0.000457	0.000842	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Temozolomide—melanoma	0.000454	0.000837	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Temozolomide—melanoma	0.000453	0.000836	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Temozolomide—melanoma	0.000449	0.000829	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Carmustine—melanoma	0.000448	0.000827	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Bleomycin—melanoma	0.000447	0.000825	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Docetaxel—melanoma	0.000446	0.000824	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Carmustine—melanoma	0.000445	0.000821	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Docetaxel—melanoma	0.000444	0.00082	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Docetaxel—melanoma	0.000443	0.000818	CcSEcCtD
Medroxyprogesterone Acetate—Methylprednisolone—ABCB1—melanoma	0.000443	0.0587	CrCbGaD
Medroxyprogesterone Acetate—Chills—Docetaxel—melanoma	0.000441	0.000814	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Bleomycin—melanoma	0.000441	0.000813	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Docetaxel—melanoma	0.000435	0.000802	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Temozolomide—melanoma	0.000433	0.000799	CcSEcCtD
Medroxyprogesterone Acetate—PGR—lymph node—melanoma	0.000431	0.018	CbGeAlD
Medroxyprogesterone Acetate—Mental disorder—Docetaxel—melanoma	0.000431	0.000795	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Carmustine—melanoma	0.00043	0.000793	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Carmustine—melanoma	0.00043	0.000793	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Temozolomide—melanoma	0.00043	0.000793	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Docetaxel—melanoma	0.000428	0.00079	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Docetaxel—melanoma	0.000428	0.00079	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Dactinomycin—melanoma	0.000428	0.00079	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Docetaxel—melanoma	0.000419	0.000774	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Temozolomide—melanoma	0.000417	0.00077	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Dactinomycin—melanoma	0.000417	0.000769	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Temozolomide—melanoma	0.000415	0.000767	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Temozolomide—melanoma	0.000415	0.000767	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Docetaxel—melanoma	0.000414	0.000764	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Docetaxel—melanoma	0.000412	0.00076	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Carmustine—melanoma	0.000401	0.000739	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Dactinomycin—melanoma	0.000398	0.000734	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Bleomycin—melanoma	0.000396	0.000731	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Docetaxel—melanoma	0.000396	0.00073	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Bleomycin—melanoma	0.000393	0.000725	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Bleomycin—melanoma	0.000392	0.000724	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Carmustine—melanoma	0.00039	0.00072	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Temozolomide—melanoma	0.000387	0.000714	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Docetaxel—melanoma	0.000384	0.000709	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Docetaxel—melanoma	0.000378	0.000698	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Temozolomide—melanoma	0.000377	0.000696	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Docetaxel—melanoma	0.000376	0.000694	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Carmustine—melanoma	0.000372	0.000687	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Temozolomide—melanoma	0.000372	0.000686	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Docetaxel—melanoma	0.000371	0.000685	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Bleomycin—melanoma	0.00037	0.000683	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Dactinomycin—melanoma	0.000369	0.000682	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Dactinomycin—melanoma	0.000366	0.000676	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Docetaxel—melanoma	0.000365	0.000673	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Docetaxel—melanoma	0.000365	0.000673	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Docetaxel—melanoma	0.000365	0.000673	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000362	0.000668	CcSEcCtD
Medroxyprogesterone Acetate—Spironolactone—ABCB1—melanoma	0.00036	0.0477	CrCbGaD
Medroxyprogesterone Acetate—Dizziness—Carmustine—melanoma	0.00036	0.000664	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Temozolomide—melanoma	0.00036	0.000663	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Docetaxel—melanoma	0.000357	0.000658	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—head—melanoma	0.000355	0.0148	CbGeAlD
Medroxyprogesterone Acetate—Confusional state—Docetaxel—melanoma	0.000352	0.00065	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Docetaxel—melanoma	0.000349	0.000645	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Docetaxel—melanoma	0.000349	0.000645	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Temozolomide—melanoma	0.000348	0.000641	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Docetaxel—melanoma	0.000347	0.000641	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Carmustine—melanoma	0.000346	0.000638	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Dactinomycin—melanoma	0.000345	0.000637	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Docetaxel—melanoma	0.000344	0.000634	CcSEcCtD
Medroxyprogesterone Acetate—AR—lymph node—melanoma	0.000344	0.0143	CbGeAlD
Medroxyprogesterone Acetate—Rash—Carmustine—melanoma	0.000343	0.000633	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Docetaxel—melanoma	0.000343	0.000632	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Carmustine—melanoma	0.000343	0.000632	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Docetaxel—melanoma	0.000342	0.000631	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Docetaxel—melanoma	0.000341	0.000629	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Carmustine—melanoma	0.000341	0.000629	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Docetaxel—melanoma	0.000339	0.000626	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—lymph node—melanoma	0.000337	0.0141	CbGeAlD
Medroxyprogesterone Acetate—Vomiting—Temozolomide—melanoma	0.000334	0.000617	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Docetaxel—melanoma	0.000333	0.000615	CcSEcCtD
Medroxyprogesterone Acetate—Methyltestosterone—ALB—melanoma	0.000333	0.044	CrCbGaD
Medroxyprogesterone Acetate—Rash—Temozolomide—melanoma	0.000331	0.000611	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Temozolomide—melanoma	0.000331	0.000611	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Temozolomide—melanoma	0.000329	0.000607	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Docetaxel—melanoma	0.000327	0.000603	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Carmustine—melanoma	0.000323	0.000596	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Docetaxel—melanoma	0.000318	0.000588	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Docetaxel—melanoma	0.000316	0.000583	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Docetaxel—melanoma	0.000314	0.000579	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Temozolomide—melanoma	0.000312	0.000576	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Docetaxel—melanoma	0.000312	0.000575	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Docetaxel—melanoma	0.000311	0.000573	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Docetaxel—melanoma	0.000308	0.000568	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Docetaxel—melanoma	0.000304	0.000561	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Docetaxel—melanoma	0.000302	0.000557	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Docetaxel—melanoma	0.000301	0.000556	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Docetaxel—melanoma	0.000299	0.000551	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Docetaxel—melanoma	0.000288	0.000531	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Docetaxel—melanoma	0.000286	0.000527	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Docetaxel—melanoma	0.000276	0.00051	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Docetaxel—melanoma	0.000276	0.00051	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Docetaxel—melanoma	0.000257	0.000475	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Docetaxel—melanoma	0.000251	0.000463	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—lymph node—melanoma	0.000249	0.0104	CbGeAlD
Medroxyprogesterone Acetate—Pruritus—Docetaxel—melanoma	0.000247	0.000456	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Docetaxel—melanoma	0.000239	0.000441	CcSEcCtD
Medroxyprogesterone Acetate—Hydrocortisone—ABCB1—melanoma	0.000239	0.0317	CrCbGaD
Medroxyprogesterone Acetate—Dizziness—Docetaxel—melanoma	0.000231	0.000426	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Docetaxel—melanoma	0.000222	0.00041	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Docetaxel—melanoma	0.00022	0.000407	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Docetaxel—melanoma	0.00022	0.000406	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Docetaxel—melanoma	0.000219	0.000404	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Docetaxel—melanoma	0.000208	0.000383	CcSEcCtD
Medroxyprogesterone Acetate—Progesterone—ABCB1—melanoma	0.000195	0.0258	CrCbGaD
Medroxyprogesterone Acetate—Testosterone—ALB—melanoma	0.000193	0.0255	CrCbGaD
Medroxyprogesterone Acetate—Testosterone—ABCB1—melanoma	0.000184	0.0244	CrCbGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—NRAS—melanoma	3.66e-05	9.28e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—FGF2—melanoma	3.65e-05	9.26e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—FN1—melanoma	3.57e-05	9.07e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HDAC2—melanoma	3.57e-05	9.05e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CXCR4—melanoma	3.57e-05	9.05e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—FOXO4—melanoma	3.57e-05	9.05e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—MYC—melanoma	3.53e-05	8.95e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GNAQ—melanoma	3.53e-05	8.95e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MAPK3—melanoma	3.5e-05	8.89e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NOTCH1—melanoma	3.5e-05	8.87e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—MYC—melanoma	3.48e-05	8.81e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—VCAN—melanoma	3.46e-05	8.77e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PTEN—melanoma	3.43e-05	8.71e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CD80—melanoma	3.43e-05	8.69e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—APC—melanoma	3.42e-05	8.68e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PIK3CG—melanoma	3.42e-05	8.68e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—KIT—melanoma	3.42e-05	8.68e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MDM2—melanoma	3.42e-05	8.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MYC—melanoma	3.41e-05	8.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—EGF—melanoma	3.38e-05	8.58e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—ERBB2—melanoma	3.37e-05	8.54e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MAPK1—melanoma	3.33e-05	8.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—EGFR—melanoma	3.33e-05	8.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PIK3CB—melanoma	3.32e-05	8.43e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SYK—melanoma	3.32e-05	8.41e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PLCB4—melanoma	3.31e-05	8.4e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.27e-05	8.3e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ITGAV—melanoma	3.26e-05	8.26e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NGFR—melanoma	3.26e-05	8.26e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AKT3—melanoma	3.26e-05	8.26e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—BRAF—melanoma	3.22e-05	8.15e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CXCL8—melanoma	3.19e-05	8.1e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.16e-05	8.01e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—NOTCH1—melanoma	3.16e-05	8.01e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—KRAS—melanoma	3.15e-05	7.99e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PLA2G6—melanoma	3.13e-05	7.95e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IGF1—melanoma	3.13e-05	7.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CDKN1B—melanoma	3.12e-05	7.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SLC6A11—melanoma	3.11e-05	7.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PIP4K2A—melanoma	3.11e-05	7.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—NOTCH1—melanoma	3.11e-05	7.89e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CASP3—melanoma	3.06e-05	7.75e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL2—melanoma	3.05e-05	7.74e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—MTAP—melanoma	3.03e-05	7.68e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MAP2K1—melanoma	3.03e-05	7.68e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SOCS1—melanoma	3.01e-05	7.65e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PIK3CD—melanoma	3.01e-05	7.63e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—S100B—melanoma	3.01e-05	7.63e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—PPARG—melanoma	2.98e-05	7.56e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—MAPK3—melanoma	2.98e-05	7.55e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCND1—melanoma	2.97e-05	7.54e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CTNNB1—melanoma	2.95e-05	7.47e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—PPARG—melanoma	2.93e-05	7.44e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP17A1—melanoma	2.92e-05	7.4e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—MYC—melanoma	2.89e-05	7.34e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PIK3CA—melanoma	2.89e-05	7.34e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MMP9—melanoma	2.89e-05	7.33e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—FGF2—melanoma	2.88e-05	7.3e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.88e-05	7.3e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CDKN1A—melanoma	2.88e-05	7.3e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ERBB4—melanoma	2.88e-05	7.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PTEN—melanoma	2.87e-05	7.28e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NFKB1—melanoma	2.86e-05	7.25e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CDKN2B—melanoma	2.85e-05	7.23e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	2.84e-05	7.21e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—VCAN—melanoma	2.81e-05	7.14e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CD86—melanoma	2.76e-05	6.99e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GNA11—melanoma	2.76e-05	6.99e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EDN1—melanoma	2.74e-05	6.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—LUM—melanoma	2.7e-05	6.85e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PHGDH—melanoma	2.7e-05	6.85e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—FASN—melanoma	2.7e-05	6.84e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MDM2—melanoma	2.69e-05	6.83e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—HRAS—melanoma	2.68e-05	6.79e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—FGF1—melanoma	2.67e-05	6.78e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CSF2—melanoma	2.67e-05	6.78e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.66e-05	6.76e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—ERBB2—melanoma	2.66e-05	6.74e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—SLC5A5—melanoma	2.65e-05	6.73e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HPSE—melanoma	2.65e-05	6.71e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PIK3CB—melanoma	2.62e-05	6.65e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—E2F1—melanoma	2.62e-05	6.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CUBN—melanoma	2.6e-05	6.59e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—VEGFA—melanoma	2.59e-05	6.58e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PDGFRA—melanoma	2.59e-05	6.57e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.57e-05	6.52e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—STAT3—melanoma	2.57e-05	6.51e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PRKCA—melanoma	2.56e-05	6.5e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ITGB3—melanoma	2.56e-05	6.5e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GNAQ—melanoma	2.56e-05	6.5e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CD44—melanoma	2.56e-05	6.5e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NRAS—melanoma	2.56e-05	6.5e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—IL6—melanoma	2.56e-05	6.5e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CXCL8—melanoma	2.52e-05	6.39e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SPP1—melanoma	2.51e-05	6.37e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CSPG4—melanoma	2.51e-05	6.37e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—BSG—melanoma	2.51e-05	6.37e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SDHD—melanoma	2.51e-05	6.37e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.51e-05	6.36e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MAP2K2—melanoma	2.51e-05	6.35e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.49e-05	6.3e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CDKN1B—melanoma	2.46e-05	6.24e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP1B1—melanoma	2.46e-05	6.23e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MAPK3—melanoma	2.45e-05	6.22e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GPAM—melanoma	2.43e-05	6.17e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PIK3CA—melanoma	2.42e-05	6.14e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CASP3—melanoma	2.41e-05	6.11e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL2—melanoma	2.41e-05	6.11e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MYC—melanoma	2.39e-05	6.05e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TERT—melanoma	2.38e-05	6.04e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RAC1—melanoma	2.38e-05	6.03e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP17A1—melanoma	2.37e-05	6.02e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—AKT1—melanoma	2.36e-05	5.99e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCND1—melanoma	2.35e-05	5.95e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.34e-05	5.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MAPK1—melanoma	2.33e-05	5.92e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—EGFR—melanoma	2.33e-05	5.92e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CTNNB1—melanoma	2.32e-05	5.89e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	2.31e-05	5.87e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HIF1A—melanoma	2.28e-05	5.78e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MMP9—melanoma	2.28e-05	5.78e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CDKN1A—melanoma	2.27e-05	5.76e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—MAPK3—melanoma	2.27e-05	5.75e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PTEN—melanoma	2.26e-05	5.74e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NFKB1—melanoma	2.25e-05	5.72e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GNA11—melanoma	2.24e-05	5.69e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—MYC—melanoma	2.21e-05	5.59e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—KRAS—melanoma	2.2e-05	5.59e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—FASN—melanoma	2.19e-05	5.57e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—KDR—melanoma	2.18e-05	5.53e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.17e-05	5.5e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—SLC5A5—melanoma	2.16e-05	5.48e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—FN1—melanoma	2.1e-05	5.32e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GNAQ—melanoma	2.09e-05	5.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CD44—melanoma	2.09e-05	5.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PLA2G6—melanoma	2.07e-05	5.24e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NOTCH1—melanoma	2.05e-05	5.21e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—VEGFA—melanoma	2.05e-05	5.19e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.04e-05	5.18e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—STAT3—melanoma	2.03e-05	5.14e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PIK3CA—melanoma	2.03e-05	5.14e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.02e-05	5.13e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ABCB1—melanoma	2.02e-05	5.13e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NRAS—melanoma	2.02e-05	5.12e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CD80—melanoma	2.01e-05	5.1e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—APC—melanoma	2.01e-05	5.09e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—KIT—melanoma	2.01e-05	5.09e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PIK3CG—melanoma	2.01e-05	5.09e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—AKT1—melanoma	2.01e-05	5.09e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP1B1—melanoma	2e-05	5.07e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EGF—melanoma	1.98e-05	5.03e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—AKT1—melanoma	1.98e-05	5.02e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TP53—melanoma	1.96e-05	4.97e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MAPK3—melanoma	1.94e-05	4.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—BRAF—melanoma	1.89e-05	4.79e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MYC—melanoma	1.88e-05	4.77e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HRAS—melanoma	1.87e-05	4.75e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PRKCA—melanoma	1.86e-05	4.72e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—VCAN—melanoma	1.86e-05	4.71e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ERCC2—melanoma	1.85e-05	4.68e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MAPK1—melanoma	1.84e-05	4.67e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—EGFR—melanoma	1.84e-05	4.67e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IGF1—melanoma	1.84e-05	4.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL6—melanoma	1.79e-05	4.55e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MAP2K1—melanoma	1.78e-05	4.51e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PIK3CD—melanoma	1.76e-05	4.48e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.76e-05	4.47e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—MAPK3—melanoma	1.75e-05	4.43e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—KRAS—melanoma	1.74e-05	4.41e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—MAPK3—melanoma	1.72e-05	4.36e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—MYC—melanoma	1.7e-05	4.31e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—FGF2—melanoma	1.69e-05	4.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—MYC—melanoma	1.67e-05	4.24e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—AKT1—melanoma	1.65e-05	4.2e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ABCB1—melanoma	1.65e-05	4.18e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PIK3CA—melanoma	1.6e-05	4.05e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MDM2—melanoma	1.58e-05	4.01e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP17A1—melanoma	1.57e-05	3.97e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ERBB2—melanoma	1.56e-05	3.95e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TP53—melanoma	1.55e-05	3.92e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PIK3CB—melanoma	1.54e-05	3.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—AKT1—melanoma	1.53e-05	3.88e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.53e-05	3.88e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PRKCA—melanoma	1.52e-05	3.84e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ERCC2—melanoma	1.5e-05	3.81e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GNA11—melanoma	1.48e-05	3.75e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HRAS—melanoma	1.48e-05	3.75e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CXCL8—melanoma	1.48e-05	3.75e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PIK3CG—melanoma	1.46e-05	3.7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—FASN—melanoma	1.45e-05	3.67e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CDKN1B—melanoma	1.44e-05	3.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SLC5A5—melanoma	1.42e-05	3.61e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CASP3—melanoma	1.41e-05	3.59e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL6—melanoma	1.41e-05	3.59e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL2—melanoma	1.41e-05	3.58e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PPARG—melanoma	1.41e-05	3.57e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCND1—melanoma	1.38e-05	3.49e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GNAQ—melanoma	1.38e-05	3.49e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CD44—melanoma	1.38e-05	3.49e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CTNNB1—melanoma	1.36e-05	3.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MMP9—melanoma	1.34e-05	3.39e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CDKN1A—melanoma	1.33e-05	3.38e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PTEN—melanoma	1.33e-05	3.37e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NFKB1—melanoma	1.32e-05	3.36e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP1B1—melanoma	1.32e-05	3.34e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—AKT1—melanoma	1.31e-05	3.31e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PIK3CD—melanoma	1.28e-05	3.25e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ALB—melanoma	1.27e-05	3.21e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.24e-05	3.16e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—VEGFA—melanoma	1.2e-05	3.05e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—STAT3—melanoma	1.19e-05	3.02e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PIK3CG—melanoma	1.19e-05	3.01e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NRAS—melanoma	1.19e-05	3.01e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—AKT1—melanoma	1.18e-05	2.99e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—AKT1—melanoma	1.16e-05	2.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PPARG—melanoma	1.15e-05	2.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MAPK3—melanoma	1.14e-05	2.88e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PIK3CB—melanoma	1.12e-05	2.83e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTGS2—melanoma	1.11e-05	2.81e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MYC—melanoma	1.1e-05	2.8e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ABCB1—melanoma	1.09e-05	2.75e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MAPK1—melanoma	1.08e-05	2.74e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EGFR—melanoma	1.08e-05	2.74e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PIK3CD—melanoma	1.04e-05	2.65e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALB—melanoma	1.03e-05	2.61e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—KRAS—melanoma	1.02e-05	2.59e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PRKCA—melanoma	9.99e-06	2.53e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ERCC2—melanoma	9.91e-06	2.51e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTEN—melanoma	9.65e-06	2.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PIK3CA—melanoma	9.38e-06	2.38e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PIK3CB—melanoma	9.09e-06	2.31e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TP53—melanoma	9.07e-06	2.3e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTGS2—melanoma	9.01e-06	2.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HRAS—melanoma	8.68e-06	2.2e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL6—melanoma	8.3e-06	2.11e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTEN—melanoma	7.86e-06	1.99e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PIK3CG—melanoma	7.83e-06	1.98e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AKT1—melanoma	7.66e-06	1.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PPARG—melanoma	7.55e-06	1.92e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PIK3CD—melanoma	6.88e-06	1.74e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PIK3CA—melanoma	6.81e-06	1.73e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALB—melanoma	6.79e-06	1.72e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PIK3CB—melanoma	6e-06	1.52e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTGS2—melanoma	5.94e-06	1.51e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—AKT1—melanoma	5.56e-06	1.41e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PIK3CA—melanoma	5.54e-06	1.41e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTEN—melanoma	5.18e-06	1.31e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—AKT1—melanoma	4.53e-06	1.15e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PIK3CA—melanoma	3.66e-06	9.27e-06	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—AKT1—melanoma	2.99e-06	7.57e-06	CbGpPWpGaD
